{"product_id":"lorbrena-lorlatinnib-25mg","title":"LORLADX 25 (Lorlatinib)","description":"Lorlatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults that has spread to other parts of the body. Lorlatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply.\r\n\u003ch3\u003e\u003cspan id=\"Non-small_Cell_Lung_Cancer\"\u003eNon-small Cell Lung Cancer\u003c\/span\u003e\u003c\/h3\u003e\r\nIndicated for metastatic non-small cell lung cancer (NSCLC) in patients whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test\r\n\r\n100 mg PO qDay with or without food\r\n\r\nContinue until disease progression or unacceptable toxicity\r\n\u003ch3\u003e\u003cspan id=\"Dosage_Modifications\"\u003eDosage Modifications\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003ch4\u003e\u003cspan id=\"Dosage_modifications_for_adverse_reactions\"\u003eDosage modifications for adverse reactions\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eFirst dose reduction: 75 mg qDay\u003c\/li\u003e\r\n \t\u003cli\u003eSecond dose reduction: 50 mg qDay\u003c\/li\u003e\r\n \t\u003cli\u003eUnable to tolerate 50 mg qDay: Permanently discontinue\u003c\/li\u003e\r\n\u003c\/ul\u003e","brand":"BIGBEAR Pharma, Laos PDR","offers":[{"title":"Default Title","offer_id":44797948330027,"sku":"RL1020230315300","price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/2023-06-0822.jpg?v=1787022113","url":"https:\/\/xomeds.com\/products\/lorbrena-lorlatinnib-25mg","provider":"XOMEDS","version":"1.0","type":"link"}